Contemporary OB/GYN week in review: mifepristone, HPV vaccine, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Relugolix combination therapy for uterine fibroids
A recent study reveals that relugolix combination therapy demonstrates sustained reduction in menstrual bleeding volume for women with symptomatic uterine fibroids.
Elevated bilateral salpingo-oophorectomy rates in women with disabilities
A recent study reveals heightened rates of concomitant bilateral salpingo-oophorectomy during benign hysterectomy in women with disabilities, shedding light on potential disparities and urging improved physician counseling and shared decision-making strategies.
Evaluating efficacy of active surveillance for CIN2
Discover how active surveillance, a growing approach in managing cervical intraepithelial neoplasia, offers a nuanced alternative to immediate interventions, showcasing promising regression rates and reduced risk of overtreatment.
Supreme Court to decide access on mifepristone for abortion
The Supreme Court's upcoming decision on mifepristone, a key abortion medication, may alter access, introducing potential restrictions and impacting the landscape of abortion rights.
Deciding the best treatment for uterine fibroids
Jay Goldberg, MD, ob-gyn at Einstein Medical Center of Philadelphia, outlines treatment options for uterine fibroids in patients with different needs.
Clinical pearls of pediatric dermatology
Toby Maurer, MD, professor at University of California, San Francisco, discusses dermatologic conditions commonly seen in pediatric patients.
Approaching inflammatory vulvovaginal diseases
Toby Maurer, MD, professor at University of California, San Francisco, discusses the clinical pearls of inflammatory vulvovaginal conditions and treatment.
Managing skin health in women
Toby Maurer, MD, professor at University of California, San Francisco, discusses common skin conditions seen in female patients, along with the best methods of treating these conditions.
Clinical pearls of abnormal uterine bleeding management
Jay Goldberg, MD, ob-gyn at Einstein Medical Center of Philadelphia, discusses treatment paradigms which can help clinicians manage abnormal uterine bleeding in their patients.
Disparities in kidney care access for pregnant patients
A recent study highlights significant disparities in kidney transplant and nephrology care access for pregnant patients with end-stage kidney disease, revealing reduced survival rates and limited access to crucial care compared to non-pregnancy-related causes.
Contemporary OB/GYN week in review: menstrual health, infertility, and more
Mediterranean diet linked to improved pregnancy outcomes
A comprehensive meta-analysis scrutinizes the Mediterranean diet's impact on female reproductive health, uncovering compelling evidence that links this nutritional approach to a significant reduction in adverse pregnancy outcomes.
Study: Vaginal progesterone does not prevent preterm birth in twin gestations
A recent study revealed vaginal progesterone offers no significant reduction in preterm birth risk for twin gestations, prompting reconsideration of its proposed efficacy.
FDA grants IND clearance to DARE-VVA1 for dyspareunia
Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.
Bariatric surgery reduces pregnancy weight gain, study reveals
Findings from a nationwide study in Sweden revealed a reduction in pregnancy weight gain among women with a history of bariatric surgery, underscoring potential clinical implications.
Mosie Baby Kit receives class 2 FDA clearance for intravaginal insemination
Discover how Mosie Baby's at-home insemination kit, the first FDA-cleared of its kind, empowers individuals facing infertility challenges with an effective, easy-to-use solution for intravaginal insemination.
Link between infertility and autism spectrum disorder risk
New research uncovers a connection between infertility and autism spectrum disorder risk, prompting a closer look at perinatal influences and the potential impact of fertility treatments on the developmental trajectory of children.
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive
Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.
Exploring menstrual health: Insights from the Avon longitudinal study
Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
How plasma biomarkers illuminate brain health in women with HIV
Discoveries from a comprehensive study reveal specific plasma biomarkers that may serve as indicators of neurological well-being in individuals living with HIV, shedding light on potential links to Alzheimer's disease and emphasizing the importance of early detection for improved outcomes.
Integrating pharmacists into PPHTN management for enhanced blood pressure control
A study reveals that involving pharmacists in the care of postpartum women at risk of persistently elevated blood pressure, as presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition, can provide an effective and feasible solution to managing hypertensive disorders, reducing postpartum readmission risks, and improving overall health care access.
Disparities in reproductive health services for women with disabilities
A recent study reveals gaps in reproductive health services for women with disabilities, highlighting a 69% likelihood of encountering barriers, including logistical and access challenges.
Contemporary OB/GYN week in review: covid vaccines, hypertension, and more
Link between reproductive life span and postmenopausal muscle mass
A recent study in Menopause, the journal of The Menopause Society, suggests that a longer reproductive life span and later age at menopause may be associated with a reduced risk of low handgrip strength in postmenopausal women.
Metronidazole treatment failure and persistent bacterial vaginosis: Implications for HIV susceptibility
A recent study in Microorganisms reveals that Metronidazole treatment failure in bacterial vaginosis is linked to elevated activated T- and dendritic-cell subsets, potentially heightening susceptibility to HIV.
The impact of autoimmune disease on women
Researchers from the Hospital for Special Surgery (HSS) present new data on various reproductive health issues that affect women with autoimmune rheumatic diseases.
How physicians can boost COVID-19 vaccine uptake among Spanish-speaking pregnant individuals
Discover the crucial findings from a recent study investigating vaccine decision-making among Spanish-speaking pregnant individuals, highlighting the pivotal role doctors play in dispelling vaccine hesitancy and fostering acceptance through targeted information dissemination and culturally sensitive approaches.
NIDA study reports surge in pregnancy-associated drug overdose deaths
Researchers from the National Institute on Drug Abuse unveil a 3-fold spike in drug overdose deaths among pregnant women aged 10 to 44 years between 2018 and 2021, highlighting pervasive barriers like discrimination and stigma hindering access to life-saving treatment.
Inactivated COVID-19 vaccines in pregnancy: No impact on neonatal outcome, study finds
A comprehensive cohort study explored the impact of inactivated COVID-19 vaccines administered within 3 months before conception, revealing reassuring findings that neonatal outcomes, including preterm birth and NICU admission, remain unaffected.
2 Commerce Drive Cranbury, NJ 08512